TY - CONF
T1 - Impact of Telemedicine on Mortality, Length of Stay, and Cost among Patients in Progressive Care Units: Experience from a Large Healthcare System
AU - Armaignac, Donna Lee
AU - Saxena, Anshul
AU - Rubens, Muni
AU - Valle, Carlos
AU - Williams, Lisa-Mae
AU - Veledar, Emir
AU - Gidel, Louis
PY - 2019/10/25
Y1 - 2019/10/25
N2 - Utilizing a retrospective observational study design, this study aimed to determine whether telemedicine intervention can affect hospital mortality, length of stay, and direct costs for progressive care unit patients. Adult patients admitted to progressive care unit (PCU) as their primary admission in a large health care system between December 2011 and August 2016 (n = 16091). During the study period, PCU patients with telemedicine intervention (TPCU, n = 8091) and nontelemedicine (NTPCU, n = 8000) were compared concurrently. Primary outcome was PCU and hospital mortality. Secondary outcomes were hospital length of stay, PCU length of stay, and mean direct costs. The mean age NTPCU and TPCU patients were 63.4 years (95%CI, 62.9-63.8 yr) and 71.1 years (95% CI, 70.7-71.74 yr), respectively. All Patient Refined-Diagnosis Related Group Disease Severity (p
AB - Utilizing a retrospective observational study design, this study aimed to determine whether telemedicine intervention can affect hospital mortality, length of stay, and direct costs for progressive care unit patients. Adult patients admitted to progressive care unit (PCU) as their primary admission in a large health care system between December 2011 and August 2016 (n = 16091). During the study period, PCU patients with telemedicine intervention (TPCU, n = 8091) and nontelemedicine (NTPCU, n = 8000) were compared concurrently. Primary outcome was PCU and hospital mortality. Secondary outcomes were hospital length of stay, PCU length of stay, and mean direct costs. The mean age NTPCU and TPCU patients were 63.4 years (95%CI, 62.9-63.8 yr) and 71.1 years (95% CI, 70.7-71.74 yr), respectively. All Patient Refined-Diagnosis Related Group Disease Severity (p
UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3287
M3 - Presentation
ER -